Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/280844 
Year of Publication: 
2022
Series/Report no.: 
Working Papers No. 22-25
Publisher: 
Federal Reserve Bank of Boston, Boston, MA
Abstract: 
Using administrative records of Medicaid enrollees in Rhode Island that link their health-care information with their payroll employment records, this paper produces new stylized facts concerning the association between opioid use disorder (OUD) and employment and inquires as to whether treatment with FDA-approved medications might boost the job-finding rates of OUD patients. We find that individuals diagnosed with OUD are less likely to be employed compared with other Medicaid enrollees, that their employment tends to be more intermittent, and that they face increased job-separation risk following their initial diagnosis. In addition, commencing treatment with buprenorphine is associated with an increased job-finding rate among nonemployed OUD patients, while commencing methadone treatment is not associated with any significant change in job-finding rates. The job-separation rate and job-finding rate results are based on Cox proportional hazard regressions that control for numerous potential confounding factors. The paper discusses a variety of causal and noncausal explanations for these results in addition to their potential policy implications.
Subjects: 
Opioid use disorder
employment
job-finding rate
buprenorphine
methadone,Medicaid
Rhode Island
JEL: 
J21
J24
I18
I12
Persistent Identifier of the first edition: 
Document Type: 
Working Paper

Files in This Item:
File
Size
728.15 kB





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.